Report on Clinical Trials for Rare Diseases in Spain 2025
The Spanish Association of Laboratories for Orphan and Ultra-Orphan Drugs (AELMHU) has published the “Report on Clinical Trials for Rare Diseases in Spain 2025,” which analyzes the most relevant data on authorized clinical trials ... Read more
May 7, 2026
Advanced therapies for rare diseases require a comprehensive approach that goes beyond the healthcare sector
The Spanish Association of Laboratories for Orphan and Ultra-Orphan Drugs (AELMHU) has highlighted the need for a comprehensive approach to advanced therapies for rare diseases during its 4th ... Read more
May 5, 2026
Unmet medical needs in rare diseases
Marian Corral, director of the Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU), participated on Monday in the discussion forum “Unmet Medical Needs: Perspectives and Consensus in Light of the New ... Read more
April 21, 2026
4th Conference on Advanced Therapies for Rare Diseases
The Spanish Association for Orphan and Ultra-Orphan Drugs (AELMHU) will hold the fourth edition of the National Conference on Advanced Therapies for Rare Diseases on May 6, 2026, sponsored by CSL, ... Read more
April 15, 2026
AELMHU in the formation of the Pharmaceutical Industry Alliance
The Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) participated on Wednesday in the inaugural meeting of the Pharmaceutical Industry Alliance, chaired by Health Minister Mónica García, ... Read more
April 14, 2026
Multidisciplinary Conference on Rare Diseases
Marian Corral, executive director of the Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU), participated on Tuesday in the “Multidisciplinary Conference on Rare Diseases,” held at the Gregorio General University Hospital ... Read more
